Tag: Featured stories

While Johnson & Johnson retains the top revenue rank across the major pharma companies, Eli Lilly last year established itself ...

Once fully operational, the Pennsylvania site will employ more than 500 people and make cell therapies for thousands of patients ...

Incoming PhRMA Chair Paul Hudson, a day before the White House announcement, pledged to work with the administration as the ...

Bristol Myers Squibb is dropping at least $3.5 billion to jointly develop the bispecific antibody, which will race with Summit ...